GARDE: Open-Source Platform for Population-based Genetic Testing of Hereditary Cancer Syndromes
When: Jul. 25th, 2024 10:00 am - 11:00 am
Learning Level: Any
To Know
About this Class
Join us for an informative webinar on the GARDE software where Dr. Del Fiol will describe how GARDE works, how GARDE has been implemented to support population-based genetic testing, the GARDE chatbot, and results of population analyses using GARDE.
GARDE is a software platform that uses:
1) algorithms to identify individuals who are eligible for genetic testing of hereditary cancer syndromes based on their family history recorded in electronic health records (EHRs); and
2) automated chatbots for patient outreach, education, and access to genetic testing. GARDE has been deployed at University of Utah Health and New York University Langone Health (NYU) to support the Cancer Moonshot-funded BRIDGE trial, and more recently at Medical University of South Carolina (MUSC) and Weill Cornell Medicine.
For questions contact Daoud Meerzaman or Kayla Strauss.